Amarin Corporation plc
NASDAQ:AMRNBiotechnology
+$0.29 today
- Market cap
- $232.89M
- Beta
- 0.82
- P/E (TTM)
- -9.9
- EPS (TTM)
- -$1.62
Volume 0.09M
Average 0.07M
Income Statement
Follow revenue through to earnings.
Revenue
$213.65M
FY 2025 · Annual
-6.5% YoYOperating Income
-$13.94M
FY 2025 · Annual
Net Income
-$38.80M
FY 2025 · Annual
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 583.19M | 369.19M | 306.91M | 228.61M | 213.65M |
| Cost of Revenue | 121.33M | 126.71M | 141.37M | 147.23M | 92.78M |
| Gross Profit | 461.86M | 242.48M | 165.54M | 81.38M | 120.87M |
| Gross Margin | 79.2% | 65.7% | 53.9% | 35.6% | 56.6% |
| Research & Development | 29.31M | 30.41M | 22.22M | 20.87M | 19.81M |
| Selling, General & Admin | 408.33M | 304.42M | 199.94M | 152.31M | 115M |
| Operating Expenses | 451.36M | 348.35M | 222.16M | 173.18M | 134.81M |
| Depreciation & Amortization | 2.86M | 3.1M | 2.97M | 3.01M | 3.03M |
| EBITDA | 14.28M | (100.69M) | (50.7M) | (74.18M) | (33.01M) |
| EBITDA Margin | 2.4% | -27.3% | -16.5% | -32.4% | -15.5% |
| Operating Income | 10.5M | (105.87M) | (56.62M) | (91.8M) | (13.94M) |
| Operating Margin | 1.8% | -28.7% | -18.4% | -40.2% | -6.5% |
| Interest Income | 1.22M | 2.82M | 11.86M | 13.4M | 10.85M |
| Interest Expense | 129K | 15K | 8K | 7K | 7K |
| Other Income / Expenses | 789K | 2.06M | 2.95M | 14.6M | (22.11M) |
| Income Before Tax | 11.29M | (103.81M) | (53.67M) | (77.2M) | (36.05M) |
| Pre-Tax Margin | 1.9% | -28.1% | -17.5% | -33.8% | -16.9% |
| Income Tax Expense | 3.56M | 2M | 5.44M | 4.98M | 2.75M |
| Net Income | 7.73M | (105.8M) | (59.11M) | (82.18M) | (38.8M) |
| Net Margin | 1.3% | -28.7% | -19.3% | -35.9% | -18.2% |
| EPS (Basic) | 0.39 | (5.20) | (3.00) | (4.00) | (1.80) |
| EPS (Diluted) | 0.38 | (5.20) | (3.00) | (4.00) | (1.80) |
| 19.8M | 20.06M | 19.7M | 20.55M | 20.75M | |
| 20.12M | 20.06M | 20.38M | 20.55M | 20.75M |
AMRN Earnings Waterfall · TTM
NASDAQ:AMRN · Revenue to Net Income
Key Ratios
Analysis
$214.9M of revenue converted into -$33.6M of net income for the selected period. Gross margin is 50.2% and net margin is -15.4%, showing how much revenue survives after costs and taxes. EPS is $-1.62, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Oct 28, 2026 | |
| 10-Q | Quarterly report | Oct 28, 2026 | |
| SC 13D/A | SC 13D/A filing | Aug 27, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 3, 2026 | |
| 10-Q | Quarterly report | Jul 29, 2026 |
How much revenue does AMRN generate?
Amarin Corporation plc (AMRN) reported $213.65M of revenue in fiscal 2025.
Is AMRN profitable?
Amarin Corporation plc (AMRN) reported -$38.80M of net income, with a net margin of -18.2%.
Continue the stock analysis
Jump to another research area for this company.